BACK TO TOP
AMYC: The Academic Myeloma Consortium

 

WELCOME TO THE ACADEMIC MYELOMA CONSORTIUM

Dedicated to Research that Advances Myeloma Treatment

The Academic Myeloma Consortium is an innovative research model that has brought together an expert team of institutions and investigators to design and rapidly complete clinical trials in myeloma with the ultimate goal of identifying new drugs to treat this disease.

 

About Us

WHAT IS THE ACADEMIC MYELOMA CONSORTIUM?

The Academic Myeloma Consortium is an innovative and focused full service research model that has combined expertise in carrying out the operational components of oncology clinical research with a group of key opinion leaders in myeloma treatment and translational research.

 

Our Mission:
  • Dedication to research that advances myeloma treatment

 

Our Vision:
  • To identify new agents and combinations which can change the treatment paradigm for myeloma

 

Our Objectives:
  • Foster a collaborative environment for the development of innovative and strategic trials
  • Support these trials from concept to completion with an experienced operational team
  • Produce rapid trial results, facilitating go/no-go decisions for new treatments in myeloma
  • Leverage our translational expertise to reach measurable and definitive endpoints

 

GET TO KNOW US!

Live Chat DOWNLOAD OUR BROCHURE